全球新生兒重症監護市場，按類型（週邊導管、中心導管、導管導入器及配件）、產品（嬰兒保暖器、培養箱、呼吸設備、新生兒監護設備、可轉換式保暖培養箱、光療設備、導管、其他）、應用（藥物管理、輸血、診斷檢測、餵食）、最終用戶（醫院、診所、門診手術中心）、國家/地區（美國、加拿大國家/地區大利、英國、法國、西班牙、荷蘭、比利時、瑞士、土耳其、俄羅斯、歐洲其他地區、日本、中國、印度、韓國、澳洲、新加坡、馬來西亞、泰國、印尼、菲律賓、亞太其他地區、巴西、阿根廷、南美其他地區、南非、沙烏地阿拉伯、阿聯酋、埃及、以色列、中東和非洲其他地區）劃分，產業趨勢及2028年的預測
市場分析與洞察：全球新生兒加護病房
預計2021年至2028年期間，新生兒加護病房將成長。根據Data Bridge Market Research分析，到2028年，該市場規模將達到95.7222億美元，在上述預測期間內複合年增長率（CAGR）為5.02%。醫生和患者對新生兒重症監護益處的認識不斷提高，這將進一步為市場成長創造有利機會。
新生兒加護病房也稱為特殊護理病房。對於早產兒來說，新生兒加護病房是一個極其複雜且設備先進的單元，配備了專業的醫護人員和專家。所有已開發國家的診所、醫院或主要衛生中心都設有自己的新生兒護理單位。
全球新生兒慢性疾病患者數量激增、早產率上升、人們對可及的產前和新生兒重症監護設備的認知度不斷提高、發展中地區的高出生率以及政府扶持政策的普及，都是推動2021-2028年新生兒重症監護市場增長的主要因素。另一方面，新生兒重症監護設備的技術進步、人均醫療支出增加以及醫療基礎設施投資的激增，也將創造大量機遇，進一步促進上述預測期內新生兒重症監護市場的成長。
發展中國家缺乏相關意識和經濟限制，以及已開發國家出生率下降，都可能成為上述預測期內新生兒重症監護市場成長的限制因素。此外，缺乏監管部門的批准和呼吸設備將成為市場成長面臨的最大挑戰。
這份新生兒重症監護市場報告詳細介紹了近期新發展動態、貿易法規、進出口分析、生產分析、價值鏈優化、市場份額、國內外市場參與者的影響、新興收入來源的機遇分析、市場法規變化、戰略市場增長分析、市場規模、各細分市場增長、應用領域及主導地位、產品審批、產品發布、地域擴張以及市場技術創新。如需了解更多關於新生兒重症監護市場的信息，請聯繫Data Bridge Market Research索取分析師簡報，我們的團隊將協助您做出明智的市場決策，實現市場成長。
全球新生兒重症監護市場範圍與市場規模
新生兒重症監護市場按產品、類型、應用和最終用戶進行細分。這些細分市場的成長將有助於您分析行業中成長緩慢的細分市場，並為用戶提供有價值的市場概覽和市場洞察，以幫助他們制定策略決策，從而確定核心市場應用。
- 依產品類型，新生兒加護病房可細分為嬰兒保暖器、保溫箱、呼吸設備、新生兒監護設備、保暖保溫箱兩用器、光療設備、導管及其他。嬰兒保暖器可細分為電加熱嬰兒保暖器和非電加熱嬰兒保暖器。呼吸設備又可細分為新生兒呼吸器、經皮氧/二氧化碳監測儀、復甦器及其他。新生兒監護設備又可細分為心肺監視器、血壓監測儀、脈搏血氧儀、二氧化碳監測儀及其他。
- 新生兒重症監護市場也根據最終用戶細分為醫院、診所和門診手術中心。
- 根據類型，新生兒重症監護市場可分為外周導管、中心靜脈導管以及導管導入器和配件。週邊導管可細分為週邊靜脈導管（PIVC）及中線導管（延長留置時間）。中心靜脈導管又可細分為經由周邊靜脈置入的中心靜脈導管（PICC）、中心靜脈導管（CVC）、植入式輸液港及臍導管。導管導入器和配件可細分為皮下和靜脈內兩種類型。
- 根據應用領域，新生兒重症監護市場可分為藥物管理、輸血、診斷測試和餵食。
新生兒重症監護市場國家層級分析
如上所述，對新生兒重症監護市場進行分析，並按國家、產品、類型、應用和最終用戶提供市場規模洞察和趨勢。
新生兒重症監護市場報告涵蓋的國家包括：北美洲的美國、加拿大和墨西哥；歐洲的德國、法國、英國、荷蘭、瑞士、比利時、俄羅斯、義大利、西班牙、土耳其和歐洲其他地區；亞太地區的中國、日本、印度、韓國、新加坡、馬來西亞、澳洲、泰國、印尼、菲律賓和亞太地區其他地區；中東和非洲地區的沙烏地阿拉伯、阿聯酋、南非、其他南美洲和其他地區的歐洲地區；
由於新生兒先天性疾病的盛行率不斷上升、新生兒人口不斷增加以及該地區政府的支持，北美在新生兒重症監護市場佔據主導地位；而由於歐洲擁有完善的醫療保健系統以及該地區寵物保險覆蓋範圍的擴大，預計歐洲在 2021 年至 2028 年的預測期內將以最高的增長率增長。
新生兒重症監護市場報告的國別部分還提供了影響各個市場的因素以及國內市場監管變化，這些因素和變化會影響市場的當前和未來趨勢。消費量、生產地點和產量、進出口分析、價格趨勢分析、原材料成本、下游和上游價值鏈分析等數據點是預測各國市場前景的主要指標。此外，在提供國別數據預測分析時，還會考慮全球品牌的市場佔有率和可用性，以及它們因本地和國內品牌的激烈競爭或稀缺競爭而面臨的挑戰，以及國內關稅和貿易路線的影響。
醫療保健基礎設施成長、已安裝基礎和新技術滲透率
新生兒重症監護市場報告還提供詳細的市場分析，涵蓋各國醫療保健支出增長情況（包括資本設備）、新生兒重症監護市場各類產品的裝機量、技術生命週期曲線的影響以及醫療保健監管環境的變化及其對新生兒重症監護市場的影響。數據涵蓋2010年至2019年的歷史時期。
競爭格局及新生兒加護病房市場佔有率分析
新生兒重症監護市場競爭格局分析按競爭對手提供詳細信息，包括公司概況、財務狀況、收入、市場潛力、研發投入、新市場拓展計劃、全球佈局、生產基地及設施、產能、公司優勢與劣勢、產品發布、產品線寬度與廣度以及應用領域優勢。以上數據僅與各公司在新生兒加護病房的業務相關。
本新生兒加護病房報告涵蓋的主要企業包括：B. Braun Melsungen AG；BD；Cook；Digicare Biomedical；Medtronic；Koninklijke Philips NV；Phoenix Medical Systems (P) Ltd；Smiths Group PLC；Teleflex Incorporated；Utah Products Products；Phoenix Medical Systems (P) Ltd；Smiths Group PLC；Teleflex Incorporated；Utah Products Products) 和英國；AngioDyUKics； Healthcare Group plc；Drägerwerk AG & Co. KGaA；nice Neotech Medical Systems Pvt. Ltd.；LYNOR HEALTHCARE PVT. LTD.；Ibis Medical；以及其他國內外企業。報告分別提供全球、北美、歐洲、亞太地區、中東和非洲以及南美洲的市佔率數據。 DBMR分析師深入了解各企業的競爭優勢，並對每位競爭對手進行單獨的競爭分析。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL NEONATAL INTENSIVE CARE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL NEONATAL INTENSIVE CARE MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL NEONATAL INTENSIVE CARE MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTAL ANALYSIS
5.2 PORTER’S FIVE FORCES
5.3 ECONOMIC IMPACT OF DONOR MILK IN THE NEONATAL INTENSIVE CARE UNIT
5.4 CLINICAL GUIDELINES FOR HUMAN MILK BANKS AND DONOR MILK USE IN THE NEONATAL INTENSIVE CARE UNIT
6 INDUSTRY INSIGHTS
7 REGULATORY FRAMWORK
8 GLOBAL NEONATAL INTENSIVE CARE MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 THERAPEUTIC DEVICES
8.2.1 VENTILATORS
8.2.1.1. HIGH-END VENTILATORS
8.2.1.1.1. MARKET VALUE (USD MILLION)
8.2.1.1.2. MARKET VOLUME (UNITS)
8.2.1.1.3. AVERAGE SELLING PRICE (USD)
8.2.1.2. MID-END VENTILATORS
8.2.1.2.1. MARKET VALUE (USD MILLION)
8.2.1.2.2. MARKET VOLUME (UNITS)
8.2.1.2.3. AVERAGE SELLING PRICE (USD)
8.2.1.3. BASIC VENTILATORS
8.2.1.3.1. MARKET VALUE (USD MILLION)
8.2.1.3.2. MARKET VOLUME (UNITS)
8.2.1.3.3. AVERAGE SELLING PRICE (USD)
8.2.2 SYRINGE PUMP
8.2.2.1. MARKET VALUE (USD MILLION)
8.2.2.2. MARKET VOLUME (UNITS)
8.2.2.3. AVERAGE SELLING PRICE (USD)
8.2.3 DEFIBRILLATOR & SUCTION PUMP
8.2.3.1. MARKET VALUE (USD MILLION)
8.2.3.2. MARKET VOLUME (UNITS)
8.2.3.3. AVERAGE SELLING PRICE (USD)
8.2.4 PHOTOTHERAPY EQUIPMENT
8.2.4.1. MARKET VALUE (USD MILLION)
8.2.4.2. MARKET VOLUME (UNITS)
8.2.4.3. AVERAGE SELLING PRICE (USD)
8.3 PATIENT MONITORING DEVICES
8.3.1 CARDIAC MONITORING DEVICES
8.3.1.1. ECG DEVICES
8.3.1.1.1. MARKET VALUE (USD MILLION)
8.3.1.1.2. MARKET VOLUME (UNITS)
8.3.1.1.3. AVERAGE SELLING PRICE (USD)
8.3.1.2. IMPLANTABLE LOOP RECORDERS
8.3.1.2.1. MARKET VALUE (USD MILLION)
8.3.1.2.2. MARKET VOLUME (UNITS)
8.3.1.2.3. AVERAGE SELLING PRICE (USD)
8.3.1.3. EVENT MONITORS
8.3.1.3.1. MARKET VALUE (USD MILLION)
8.3.1.3.2. MARKET VOLUME (UNITS)
8.3.1.3.3. AVERAGE SELLING PRICE (USD)
8.3.2 MULTI-PARAMETER MONITORING DEVICES
8.3.2.1. LOW-ACUITY MONITORING DEVICES
8.3.2.1.1. MARKET VALUE (USD MILLION)
8.3.2.1.2. MARKET VOLUME (UNITS)
8.3.2.1.3. AVERAGE SELLING PRICE (USD)
8.3.2.2. MID-ACUITY MONITORING DEVICES
8.3.2.2.1. MARKET VALUE (USD MILLION)
8.3.2.2.2. MARKET VOLUME (UNITS)
8.3.2.2.3. AVERAGE SELLING PRICE (USD)
8.3.2.3. HIGH-ACUITY MONITORING DEVICES
8.3.2.3.1. MARKET VALUE (USD MILLION)
8.3.2.3.2. MARKET VOLUME (UNITS)
8.3.2.3.3. AVERAGE SELLING PRICE (USD)
8.3.3 RESPIRATORY MONITORING DEVICES
8.3.3.1. PULSE OXIMETERS
8.3.3.1.1. MARKET VALUE (USD MILLION)
8.3.3.1.2. MARKET VOLUME (UNITS)
8.3.3.1.3. AVERAGE SELLING PRICE (USD)
8.3.3.2. SPIROMETERS
8.3.3.2.1. MARKET VALUE (USD MILLION)
8.3.3.2.2. MARKET VOLUME (UNITS)
8.3.3.2.3. AVERAGE SELLING PRICE (USD)
8.3.3.3. CAPNOGRAPHS
8.3.3.3.1. MARKET VALUE (USD MILLION)
8.3.3.3.2. MARKET VOLUME (UNITS)
8.3.3.3.3. AVERAGE SELLING PRICE (USD)
8.3.3.4. PEAK FLOW METERS
8.3.3.4.1. MARKET VALUE (USD MILLION)
8.3.3.4.2. MARKET VOLUME (UNITS)
8.3.3.4.3. AVERAGE SELLING PRICE (USD)
8.3.4 TEMPERATURE MONITORING DEVICES
8.3.4.1. HANDHELD TEMPERATURE MONITORING DEVICES
8.3.4.1.1. MARKET VALUE (USD MILLION)
8.3.4.1.2. MARKET VOLUME (UNITS)
8.3.4.1.3. AVERAGE SELLING PRICE (USD)
8.3.4.2. TABLE-TOP TEMPERATURE MONITORING DEVICES
8.3.4.2.1. MARKET VALUE (USD MILLION)
8.3.4.2.2. MARKET VOLUME (UNITS)
8.3.4.2.3. AVERAGE SELLING PRICE (USD)
8.3.4.3. INVASIVE TEMPERATURE MONITORING DEVICES
8.3.4.3.1. MARKET VALUE (USD MILLION)
8.3.4.3.2. MARKET VOLUME (UNITS)
8.3.4.3.3. AVERAGE SELLING PRICE (USD)
8.3.5 HEMODYNAMIC/PRESSURE MONITORING DEVICES
8.3.5.1. HEMODYNAMIC MONITORS
8.3.5.1.1. MARKET VALUE (USD MILLION)
8.3.5.1.2. MARKET VOLUME (UNITS)
8.3.5.1.3. AVERAGE SELLING PRICE (USD)
8.3.5.2. BLOOD PRESSURE MONITORS
8.3.5.2.1. MARKET VALUE (USD MILLION)
8.3.5.2.2. MARKET VOLUME (UNITS)
8.3.5.2.3. AVERAGE SELLING PRICE (USD)
8.3.5.3. DISPOSABLES
8.3.5.3.1. MARKET VALUE (USD MILLION)
8.3.5.3.2. MARKET VOLUME (UNITS)
8.3.5.3.3. AVERAGE SELLING PRICE (USD)
8.3.6 NEUROMONITORING DEVICES
8.3.6.1. ELECTROENCEPHALOGRAPH MACHINES
8.3.6.1.1. MARKET VALUE (USD MILLION)
8.3.6.1.2. MARKET VOLUME (UNITS)
8.3.6.1.3. AVERAGE SELLING PRICE (USD)
8.3.6.2. ELECTROMYOGRAPHY MACHINES
8.3.6.2.1. MARKET VALUE (USD MILLION)
8.3.6.2.2. MARKET VOLUME (UNITS)
8.3.6.2.3. AVERAGE SELLING PRICE (USD)
8.3.6.3. CEREBRAL OXIMETERS
8.3.6.3.1. MARKET VALUE (USD MILLION)
8.3.6.3.2. MARKET VOLUME (UNITS)
8.3.6.3.3. AVERAGE SELLING PRICE (USD)
8.3.6.4. INTRACRANIAL PRESSURE MONITORS
8.3.6.4.1. MARKET VALUE (USD MILLION)
8.3.6.4.2. MARKET VOLUME (UNITS)
8.3.6.4.3. AVERAGE SELLING PRICE (USD)
8.3.6.5. MAGNETOENCEPHALOGRAPH MACHINES
8.3.6.5.1. MARKET VALUE (USD MILLION)
8.3.6.5.2. MARKET VOLUME (UNITS)
8.3.6.5.3. AVERAGE SELLING PRICE (USD)
8.3.6.6. TRANSCRANIAL DOPPLER MACHINES
8.3.6.6.1. MARKET VALUE (USD MILLION)
8.3.6.6.2. MARKET VOLUME (UNITS)
8.3.6.6.3. AVERAGE SELLING PRICE (USD)
8.4 DIAGNOSTIC DEVICES
8.4.1 ULTRASONOGRAPHY MACHINE
8.4.1.1. MARKET VALUE (USD MILLION)
8.4.1.2. MARKET VOLUME (UNITS)
8.4.1.3. AVERAGE SELLING PRICE (USD)
8.4.2 ELECTROCARDIOGRAM (ECG) MACHINE
8.4.2.1. MARKET VALUE (USD MILLION)
8.4.2.2. MARKET VOLUME (UNITS)
8.4.2.3. AVERAGE SELLING PRICE (USD)
8.4.3 MOBILE X-RAY MACHINE
8.4.3.1. MARKET VALUE (USD MILLION)
8.4.3.2. MARKET VOLUME (UNITS)
8.4.3.3. AVERAGE SELLING PRICE (USD)
8.4.4 ABG MACHINE
8.4.4.1. MARKET VALUE (USD MILLION)
8.4.4.2. MARKET VOLUME (UNITS)
8.4.4.3. AVERAGE SELLING PRICE (USD)
8.5 ICU UNITS & SYSTEMS
8.5.1 MEDICAL SUPPLY SYSTEMS
8.5.1.1. CEILING SUPPLY UNIT
8.5.1.1.1. MARKET VALUE (USD MILLION)
8.5.1.1.2. MARKET VOLUME (UNITS)
8.5.1.1.3. AVERAGE SELLING PRICE (USD)
8.5.1.2. CEILING ARM SYSTEM
8.5.1.2.1. MARKET VALUE (USD MILLION)
8.5.1.2.2. MARKET VOLUME (UNITS)
8.5.1.2.3. AVERAGE SELLING PRICE (USD)
8.5.1.3. CEILING BEAM SYSTEM
8.5.1.3.1. MARKET VALUE (USD MILLION)
8.5.1.3.2. MARKET VOLUME (UNITS)
8.5.1.3.3. AVERAGE SELLING PRICE (USD)
8.5.1.4. WALL-MOUNT SYSTEM
8.5.1.4.1. MARKET VALUE (USD MILLION)
8.5.1.4.2. MARKET VOLUME (UNITS)
8.5.1.4.3. AVERAGE SELLING PRICE (USD)
8.5.1.5. WALL SUPPLY UNIT
8.5.1.5.1. MARKET VALUE (USD MILLION)
8.5.1.5.2. MARKET VOLUME (UNITS)
8.5.1.5.3. AVERAGE SELLING PRICE (USD)
8.5.2 SURGICAL AND EXAMINATION LIGHTS
8.5.2.1. MEDICAL LIGHTS
8.5.2.1.1. MARKET VALUE (USD MILLION)
8.5.2.1.2. MARKET VOLUME (UNITS)
8.5.2.1.3. AVERAGE SELLING PRICE (USD)
8.5.2.2. SURGICAL LIGHT
8.5.2.2.1. MARKET VALUE (USD MILLION)
8.5.2.2.2. MARKET VOLUME (UNITS)
8.5.2.2.3. AVERAGE SELLING PRICE (USD)
8.5.2.3. EXAMINATION LIGHT
8.5.2.3.1. MARKET VALUE (USD MILLION)
8.5.2.3.2. MARKET VOLUME (UNITS)
8.5.2.3.3. AVERAGE SELLING PRICE (USD)
8.5.3 OTHERS
8.6 OTHER DEVICES
8.6.1 INFUSION PUMPS
8.6.1.1. MARKET VALUE (USD MILLION)
8.6.1.2. MARKET VOLUME (UNITS)
8.6.1.3. AVERAGE SELLING PRICE (USD)
8.6.2 SLEEP APNEA DEVICES
8.6.2.1. MARKET VALUE (USD MILLION)
8.6.2.2. MARKET VOLUME (UNITS)
8.6.2.3. AVERAGE SELLING PRICE (USD)
8.6.3 BLOOD WARMER
8.6.3.1. MARKET VALUE (USD MILLION)
8.6.3.2. MARKET VOLUME (UNITS)
8.6.3.3. AVERAGE SELLING PRICE (USD)
8.6.4 INFANT WARMERS & INCUBATORS
8.6.4.1. TRANSPORT INCUBATOR
8.6.4.1.1. EXTERNAL TRANSPORT INCUBATOR
8.6.4.1.1.1 MARKET VALUE (USD MILLION)
8.6.4.1.1.2 MARKET VOLUME (UNITS)
8.6.4.1.1.3 AVERAGE SELLING PRICE (USD)
8.6.4.1.2. INTERNAL TRANSPORT INCUBATOR
8.6.4.1.2.1 MARKET VALUE (USD MILLION)
8.6.4.1.2.2 MARKET VOLUME (UNITS)
8.6.4.1.2.3 AVERAGE SELLING PRICE (USD)
8.6.4.2. LABOR AND DELIVERY
8.6.4.2.1. LABOR AND DELIVERY WARMER
8.6.4.2.1.1 MARKET VALUE (USD MILLION)
8.6.4.2.1.2 MARKET VOLUME (UNITS)
8.6.4.2.1.3 AVERAGE SELLING PRICE (USD)
8.6.4.2.2. LABOR AND DELIVERY INCUBATOR
8.6.4.2.2.1 MARKET VALUE (USD MILLION)
8.6.4.2.2.2 MARKET VOLUME (UNITS)
8.6.4.2.2.3 AVERAGE SELLING PRICE (USD)
8.6.4.3. NEONATAL INTENSIVE CARE UNIT (NICU)
8.6.4.3.1. NICU CONVERTIBLE WARMER/INCUBATOR
8.6.4.3.1.1 MARKET VALUE (USD MILLION)
8.6.4.3.1.2 MARKET VOLUME (UNITS)
8.6.4.3.1.3 AVERAGE SELLING PRICE (USD)
8.6.4.3.2. NICU INCUBATOR
8.6.4.3.2.1 MARKET VALUE (USD MILLION)
8.6.4.3.2.2 MARKET VOLUME (UNITS)
8.6.4.3.2.3 AVERAGE SELLING PRICE (USD)
8.6.4.3.3. NICU WARMER
8.6.4.3.3.1 MARKET VALUE (USD MILLION)
8.6.4.3.3.2 MARKET VOLUME (UNITS)
8.6.4.3.3.3 AVERAGE SELLING PRICE (USD)
8.6.5 ANESTHESIA MACHINE
8.6.5.1. MARKET VALUE (USD MILLION)
8.6.5.2. MARKET VOLUME (UNITS)
8.6.5.3. AVERAGE SELLING PRICE (USD)
8.6.6 MEDICAL ACCESSORIES AND CONSUMABLES
8.6.6.1. POSITIVE AIRWAY PRESSURE (PAP) SYSTEM
8.6.6.1.1. MARKET VALUE (USD MILLION)
8.6.6.1.2. MARKET VOLUME (UNITS)
8.6.6.1.3. AVERAGE SELLING PRICE (USD)
8.6.6.2. ANESTHESIA CIRCUIT KITS
8.6.6.2.1. MARKET VALUE (USD MILLION)
8.6.6.2.2. MARKET VOLUME (UNITS)
8.6.6.2.3. AVERAGE SELLING PRICE (USD)
8.6.6.3. ECG LEADS
8.6.6.3.1. MARKET VALUE (USD MILLION)
8.6.6.3.2. MARKET VOLUME (UNITS)
8.6.6.3.3. AVERAGE SELLING PRICE (USD)
8.6.6.4. BABYFLOW PLUS
8.6.6.4.1. MARKET VALUE (USD MILLION)
8.6.6.4.2. MARKET VOLUME (UNITS)
8.6.6.4.3. AVERAGE SELLING PRICE (USD)
8.6.6.5. CATHETERS
8.6.6.5.1. MARKET VALUE (USD MILLION)
8.6.6.5.2. MARKET VOLUME (UNITS)
8.6.6.5.3. AVERAGE SELLING PRICE (USD)
8.6.6.6. OTHERS
8.6.7 OTHERS
9 GLOBAL NEONATAL INTENSIVE CARE MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS
9.2.1 ACUTE CARE HOSPITALS
9.2.2 LONG-TERM CARE HOSPITALS
9.3 SPECIALTY CLINICS
9.4 AMBULATORY SURGICAL CENTERS
9.5 OTHERS
10 GLOBAL NEONATAL INTENSIVE CARE MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT TENDERS
10.3 RETAIL SALES
10.4 THIRD PARTY DISTRIBUTION
10.5 OTHERS
11 GLOBAL NEONATAL INTENSIVE CARE MARKET, BY GEOGRAPHY
GLOBAL NEONATAL INTENSIVE CARE MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.1.1. U.S. NEONATAL INTENSIVE CARE MARKET, BY PRODUCT TYPE
11.1.1.2. U.S. NEONATAL INTENSIVE CARE MARKET, BY END USER
11.1.1.3. U.S. NEONATAL INTENSIVE CARE MARKET, BY DISTRIBUTION CHANNEL
11.1.2 CANADA
11.1.3 MEXICO
11.2 EUROPE
11.2.1 GERMANY
11.2.2 FRANCE
11.2.3 U.K.
11.2.4 ITALY
11.2.5 SPAIN
11.2.6 RUSSIA
11.2.7 TURKEY
11.2.8 BELGIUM
11.2.9 NETHERLANDS
11.2.10 SWITZERLAND
11.2.11 REST OF EUROPE
11.3 ASIA-PACIFIC
11.3.1 JAPAN
11.3.2 CHINA
11.3.3 SOUTH KOREA
11.3.4 INDIA
11.3.5 AUSTRALIA
11.3.6 SINGAPORE
11.3.7 THAILAND
11.3.8 MALAYSIA
11.3.9 INDONESIA
11.3.10 PHILIPPINES
11.3.11 REST OF ASIA-PACIFIC
11.4 SOUTH AMERICA
11.4.1 BRAZIL
11.4.2 ARGENTINA
11.4.3 REST OF SOUTH AMERICA
11.5 MIDDLE EAST AND AFRICA
11.5.1 SOUTH AFRICA
11.5.2 SAUDI ARABIA
11.5.3 UAE
11.5.4 EGYPT
11.5.5 ISRAEL
11.5.6 REST OF MIDDLE EAST AND AFRICA
11.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
12 GLOBAL NEONATAL INTENSIVE CARE MARKET, SWOT AND DBR ANALYSIS
13 GLOBAL NEONATAL INTENSIVE CARE MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3 COMPANY SHARE ANALYSIS: EUROPE
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13.5 MERGERS & ACQUISITIONS
13.6 NEW PRODUCT DEVELOPMENT & APPROVALS
13.7 EXPANSIONS
13.8 REGULATORY CHANGES
13.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
14 GLOBAL NEONATAL INTENSIVE CARE MARKET, COMPANY PROFILE
14.1 KONINKLIJKE PHILIPS N.V.
14.1.1 COMPANY OVERVIEW
14.1.2 REVENUE ANALYSIS
14.1.3 GEOGRAPHIC PRESENCE
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 GENERAL ELECTRIC COMPANY
14.2.1 COMPANY OVERVIEW
14.2.2 REVENUE ANALYSIS
14.2.3 GEOGRAPHIC PRESENCE
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 COOK MEDICAL
14.3.1 COMPANY OVERVIEW
14.3.2 REVENUE ANALYSIS
14.3.3 GEOGRAPHIC PRESENCE
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 C. R. BARD, INC.
14.4.1 COMPANY OVERVIEW
14.4.2 REVENUE ANALYSIS
14.4.3 GEOGRAPHIC PRESENCE
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 GETINGE AB
14.5.1 COMPANY OVERVIEW
14.5.2 REVENUE ANALYSIS
14.5.3 GEOGRAPHIC PRESENCE
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 HEYER MEDICAL AG
14.6.1 COMPANY OVERVIEW
14.6.2 REVENUE ANALYSIS
14.6.3 GEOGRAPHIC PRESENCE
14.6.4 PRODUCT PORTFOLIO
14.6.5 RECENT DEVELOPMENTS
14.7 DRÄGERWERK AG & CO. KGAA
14.7.1 COMPANY OVERVIEW
14.7.2 REVENUE ANALYSIS
14.7.3 GEOGRAPHIC PRESENCE
14.7.4 PRODUCT PORTFOLIO
14.7.5 RECENT DEVELOPMENTS
14.8 MEDTRONIC
14.8.1 COMPANY OVERVIEW
14.8.2 REVENUE ANALYSIS
14.8.3 GEOGRAPHIC PRESENCE
14.8.4 PRODUCT PORTFOLIO
14.8.5 RECENT DEVELOPMENTS
14.9 B. BRAUN MELSUNGEN AG
14.9.1 COMPANY OVERVIEW
14.9.2 REVENUE ANALYSIS
14.9.3 GEOGRAPHIC PRESENCE
14.9.4 PRODUCT PORTFOLIO
14.9.5 RECENT DEVELOPMENTS
14.1 SMITHS GROUP PLC.
14.10.1 COMPANY OVERVIEW
14.10.2 REVENUE ANALYSIS
14.10.3 GEOGRAPHIC PRESENCE
14.10.4 PRODUCT PORTFOLIO
14.10.5 RECENT DEVELOPMENTS
14.11 NIHON KOHDEN CORPORATION
14.11.1 COMPANY OVERVIEW
14.11.2 REVENUE ANALYSIS
14.11.3 GEOGRAPHIC PRESENCE
14.11.4 PRODUCT PORTFOLIO
14.11.5 RECENT DEVELOPMENTS
14.12 FRESENIUS SE & CO. KGAA
14.12.1 COMPANY OVERVIEW
14.12.2 REVENUE ANALYSIS
14.12.3 GEOGRAPHIC PRESENCE
14.12.4 PRODUCT PORTFOLIO
14.12.5 RECENT DEVELOPMENTS
14.13 SKANRAY TECHNOLOGIES PVT. LTD
14.13.1 COMPANY OVERVIEW
14.13.2 REVENUE ANALYSIS
14.13.3 GEOGRAPHIC PRESENCE
14.13.4 PRODUCT PORTFOLIO
14.13.5 RECENT DEVELOPMENTS
14.14 ABBOTT
14.14.1 COMPANY OVERVIEW
14.14.2 REVENUE ANALYSIS
14.14.3 GEOGRAPHIC PRESENCE
14.14.4 PRODUCT PORTFOLIO
14.14.5 RECENT DEVELOPMENTS
14.15 SCHILLER
14.15.1 COMPANY OVERVIEW
14.15.2 REVENUE ANALYSIS
14.15.3 GEOGRAPHIC PRESENCE
14.15.4 PRODUCT PORTFOLIO
14.15.5 RECENT DEVELOPMENTS
14.16 STERIS PLC
14.16.1 COMPANY OVERVIEW
14.16.2 REVENUE ANALYSIS
14.16.3 GEOGRAPHIC PRESENCE
14.16.4 PRODUCT PORTFOLIO
14.16.5 RECENT DEVELOPMENTS
14.17 HILL-ROM SERVICES, INC.
14.17.1 COMPANY OVERVIEW
14.17.2 REVENUE ANALYSIS
14.17.3 GEOGRAPHIC PRESENCE
14.17.4 PRODUCT PORTFOLIO
14.17.5 RECENT DEVELOPMENTS
14.18 OMRON CORPORATION
14.18.1 COMPANY OVERVIEW
14.18.2 REVENUE ANALYSIS
14.18.3 GEOGRAPHIC PRESENCE
14.18.4 PRODUCT PORTFOLIO
14.18.5 RECENT DEVELOPMENTS
14.19 MASIMO
14.19.1 COMPANY OVERVIEW
14.19.2 REVENUE ANALYSIS
14.19.3 GEOGRAPHIC PRESENCE
14.19.4 PRODUCT PORTFOLIO
14.19.5 RECENT DEVELOPMENTS
14.2 COMPUMEDICS LIMITED
14.20.1 COMPANY OVERVIEW
14.20.2 REVENUE ANALYSIS
14.20.3 GEOGRAPHIC PRESENCE
14.20.4 PRODUCT PORTFOLIO
14.20.5 RECENT DEVELOPMENTS
14.21 NATUS MEDICAL
14.21.1 COMPANY OVERVIEW
14.21.2 REVENUE ANALYSIS
14.21.3 GEOGRAPHIC PRESENCE
14.21.4 PRODUCT PORTFOLIO
14.21.5 RECENT DEVELOPMENTS
14.22 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD
14.22.1 COMPANY OVERVIEW
14.22.2 REVENUE ANALYSIS
14.22.3 GEOGRAPHIC PRESENCE
14.22.4 PRODUCT PORTFOLIO
14.22.5 RECENT DEVELOPMENTS
14.23 BOSTON SCIENTIFIC CORPORATION
14.23.1 COMPANY OVERVIEW
14.23.2 REVENUE ANALYSIS
14.23.3 GEOGRAPHIC PRESENCE
14.23.4 PRODUCT PORTFOLIO
14.23.5 RECENT DEVELOPMENTS
14.24 FISHER AND PAYKEL HEALTHCARE
14.24.1 COMPANY OVERVIEW
14.24.2 REVENUE ANALYSIS
14.24.3 GEOGRAPHIC PRESENCE
14.24.4 PRODUCT PORTFOLIO
14.24.5 RECENT DEVELOPMENTS
14.25 NONIN
14.25.1 COMPANY OVERVIEW
14.25.2 REVENUE ANALYSIS
14.25.3 GEOGRAPHIC PRESENCE
14.25.4 PRODUCT PORTFOLIO
14.25.5 RECENT DEVELOPMENTS
14.26 DIXION
14.26.1 COMPANY OVERVIEW
14.26.2 REVENUE ANALYSIS
14.26.3 GEOGRAPHIC PRESENCE
14.26.4 PRODUCT PORTFOLIO
14.26.5 RECENT DEVELOPMENTS
14.27 SS TECHNOMED (P) LTD.
14.27.1 COMPANY OVERVIEW
14.27.2 REVENUE ANALYSIS
14.27.3 GEOGRAPHIC PRESENCE
14.27.4 PRODUCT PORTFOLIO
14.27.5 RECENT DEVELOPMENTS
14.28 VIA GLOBAL HEALTH
14.28.1 COMPANY OVERVIEW
14.28.2 REVENUE ANALYSIS
14.28.3 GEOGRAPHIC PRESENCE
14.28.4 PRODUCT PORTFOLIO
14.28.5 RECENT DEVELOPMENTS
14.29 CROWN HEALTHCARE
14.29.1 COMPANY OVERVIEW
14.29.2 REVENUE ANALYSIS
14.29.3 GEOGRAPHIC PRESENCE
14.29.4 PRODUCT PORTFOLIO
14.29.5 RECENT DEVELOPMENTS
14.3 ADVIN HEALTH CARE
14.30.1 COMPANY OVERVIEW
14.30.2 REVENUE ANALYSIS
14.30.3 GEOGRAPHIC PRESENCE
14.30.4 PRODUCT PORTFOLIO
14.30.5 RECENT DEVELOPMENTS
*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST RELATED REPORTS
15 CONCLUSION
16 QUESTIONNAIRE
17 ABOUT DATA BRIDGE MARKET RESEARCH
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
